Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_assertion type Assertion NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_head.
- NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_assertion description "[We further found that miR-26a exerted its antiangiogenesis function, at least in part, by inhibiting HGF-hepatocyte growth factor receptor (cMet) and its downstream signaling pathway, in turn, suppressing VEGFA production in HCC cells and impairing VEGFR2-signaling in endothelial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_provenance.
- NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_assertion evidence source_evidence_literature NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_provenance.
- NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_assertion SIO_000772 24259426 NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_provenance.
- NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_assertion wasDerivedFrom befree-20150227 NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_provenance.
- NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_assertion wasGeneratedBy ECO_0000203 NP554547.RAjQujC3nyZyRPsLNfWD8DgTOCJFAmJiMQ596fV9nBGtc130_provenance.